The EPIPSOFIRE project: A Preliminary Report

Gabriele De Marco, Angelo Cattaneo, Carlo G. Carrera, Patrizia Gibertini, Norma Battafarano, Antonio Marchesoni

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Postmarketing Phase IV Psoriatic arthritis (PsA) is a musculoskeletal condition complicating psoriasis that can lead to joint deformity and disability; however, psoriatic patients may suffer from other kind of arthropathies that could be confused with PsA by nonrheumatologists. Our aim was to determine the prevalence of PsA and to determine the prevalence of other musculoskeletal conditions in a cohort of psoriatic patients. In this cohort, musculoskeletal discomfort was frequently reported, while inflammatory disorders were detected in 20 years) or severe cutaneous disease. Because musculoskeletal discomfort symptoms affected about 62% of patients, other disorders, particularly morphologic conditions, need careful evaluation in psoriasis subjects.

Original languageEnglish
Pages (from-to)S85-S87
JournalDrug Development Research
Volume75
DOIs
Publication statusPublished - 2014

Fingerprint

Psoriatic Arthritis
Psoriasis
Joint Diseases
Skin Diseases
Joints

Keywords

  • multidisciplinary approach to psoriasis care
  • musculoskeletal discomfort
  • psoriatic arthritis

ASJC Scopus subject areas

  • Drug Discovery
  • Medicine(all)

Cite this

De Marco, G., Cattaneo, A., Carrera, C. G., Gibertini, P., Battafarano, N., & Marchesoni, A. (2014). The EPIPSOFIRE project: A Preliminary Report. Drug Development Research, 75, S85-S87. https://doi.org/10.1002/ddr.21205

The EPIPSOFIRE project : A Preliminary Report. / De Marco, Gabriele; Cattaneo, Angelo; Carrera, Carlo G.; Gibertini, Patrizia; Battafarano, Norma; Marchesoni, Antonio.

In: Drug Development Research, Vol. 75, 2014, p. S85-S87.

Research output: Contribution to journalArticle

De Marco, G, Cattaneo, A, Carrera, CG, Gibertini, P, Battafarano, N & Marchesoni, A 2014, 'The EPIPSOFIRE project: A Preliminary Report', Drug Development Research, vol. 75, pp. S85-S87. https://doi.org/10.1002/ddr.21205
De Marco G, Cattaneo A, Carrera CG, Gibertini P, Battafarano N, Marchesoni A. The EPIPSOFIRE project: A Preliminary Report. Drug Development Research. 2014;75:S85-S87. https://doi.org/10.1002/ddr.21205
De Marco, Gabriele ; Cattaneo, Angelo ; Carrera, Carlo G. ; Gibertini, Patrizia ; Battafarano, Norma ; Marchesoni, Antonio. / The EPIPSOFIRE project : A Preliminary Report. In: Drug Development Research. 2014 ; Vol. 75. pp. S85-S87.
@article{7b1e1f81bce84733a6ed60af52548f42,
title = "The EPIPSOFIRE project: A Preliminary Report",
abstract = "Postmarketing Phase IV Psoriatic arthritis (PsA) is a musculoskeletal condition complicating psoriasis that can lead to joint deformity and disability; however, psoriatic patients may suffer from other kind of arthropathies that could be confused with PsA by nonrheumatologists. Our aim was to determine the prevalence of PsA and to determine the prevalence of other musculoskeletal conditions in a cohort of psoriatic patients. In this cohort, musculoskeletal discomfort was frequently reported, while inflammatory disorders were detected in 20 years) or severe cutaneous disease. Because musculoskeletal discomfort symptoms affected about 62{\%} of patients, other disorders, particularly morphologic conditions, need careful evaluation in psoriasis subjects.",
keywords = "multidisciplinary approach to psoriasis care, musculoskeletal discomfort, psoriatic arthritis",
author = "{De Marco}, Gabriele and Angelo Cattaneo and Carrera, {Carlo G.} and Patrizia Gibertini and Norma Battafarano and Antonio Marchesoni",
year = "2014",
doi = "10.1002/ddr.21205",
language = "English",
volume = "75",
pages = "S85--S87",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - The EPIPSOFIRE project

T2 - A Preliminary Report

AU - De Marco, Gabriele

AU - Cattaneo, Angelo

AU - Carrera, Carlo G.

AU - Gibertini, Patrizia

AU - Battafarano, Norma

AU - Marchesoni, Antonio

PY - 2014

Y1 - 2014

N2 - Postmarketing Phase IV Psoriatic arthritis (PsA) is a musculoskeletal condition complicating psoriasis that can lead to joint deformity and disability; however, psoriatic patients may suffer from other kind of arthropathies that could be confused with PsA by nonrheumatologists. Our aim was to determine the prevalence of PsA and to determine the prevalence of other musculoskeletal conditions in a cohort of psoriatic patients. In this cohort, musculoskeletal discomfort was frequently reported, while inflammatory disorders were detected in 20 years) or severe cutaneous disease. Because musculoskeletal discomfort symptoms affected about 62% of patients, other disorders, particularly morphologic conditions, need careful evaluation in psoriasis subjects.

AB - Postmarketing Phase IV Psoriatic arthritis (PsA) is a musculoskeletal condition complicating psoriasis that can lead to joint deformity and disability; however, psoriatic patients may suffer from other kind of arthropathies that could be confused with PsA by nonrheumatologists. Our aim was to determine the prevalence of PsA and to determine the prevalence of other musculoskeletal conditions in a cohort of psoriatic patients. In this cohort, musculoskeletal discomfort was frequently reported, while inflammatory disorders were detected in 20 years) or severe cutaneous disease. Because musculoskeletal discomfort symptoms affected about 62% of patients, other disorders, particularly morphologic conditions, need careful evaluation in psoriasis subjects.

KW - multidisciplinary approach to psoriasis care

KW - musculoskeletal discomfort

KW - psoriatic arthritis

UR - http://www.scopus.com/inward/record.url?scp=84910023646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910023646&partnerID=8YFLogxK

U2 - 10.1002/ddr.21205

DO - 10.1002/ddr.21205

M3 - Article

C2 - 25381988

AN - SCOPUS:84910023646

VL - 75

SP - S85-S87

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

ER -